Provision

After the RBI on Tuesday identified 12 NPAs, which can be taken up under the Insolvency and Bankruptcy Code, bankers now await word on easier provisioning norms.

Bank of Baroda Q4 net loss at Rs 3230cr, provision at Rs 6858cr

Its provision in Q4FY16 increased to Rs 6858 crore compared to Rs 6164.5 crore on sequential basis and Rs 1817.5 crore YoY.

Kotak Mahindra Bank Q4 net may jump 8%, NII seen at Rs 1832 cr

Kotak Mahindra Bank is likely to see standalone net profit at Rs 689 crore in January-March quarter, up 8.5 percent from Rs 635 crore in last quarter. According to a CNBC-TV18 poll, the private lender's net interest income (NII) may jump 3.8 percent at Rs 1832 crore against Rs 1766 crore in quarter-ago period.

HDFC Q4 net rises 40% at Rs 2607 cr driven by investments sales

Provisions in Q4FY16 jumped to Rs 545 crore from Rs 68 crore on sequential basis. Provision includes Rs 450 crore towards stand assets and other contingencies.

IndusInd Bank Q4 net up 25% at Rs 620 cr; NPA rises slightly

Its asset quality became slightly weak in Q4, with gross non-performing assets at 0.87 percent versus 0.82 percent and net NPA at 0.36 percent versus 0.33 percent (QoQ). Its provisions, in Q4, was at Rs 213.6 crore against Rs 177 crore (QoQ).

PSU banks write off 38 accounts worth Rs 8,033 cr

Public sector banks have written off 38 accounts of Rs 100 crore and above amounting to about Rs 8,000 crore during the nine months of the current fiscal.

RBI inaction early on to blame for current NPA mess: Ex-SBI boss

Speaking in the same discussion, Rajat Bahl, Director, Ratings, CRISIL says the RBI's move to force banks to recognise bad assets may look like a knee-jerk reaction. But the regulator may not have been left with a choice after other measures like strategic debt restructuring and 5:25 schemes did not yield the desired results.

Bank of Baroda Q3 loss at Rs 3342cr; provisions surge 225%

Bank of Baroda posted a quarterly net loss of Rs 3342 crore, compared to Rs 124 crore quarter on quarter. The loss was driven by a 225 percent increase in provisions, which rose from Rs 1,891 crore in the previous quarter to Rs 6164 crore.

HCC expects higher turnover in Q4: CFO

Hindustan Construction Company's (HCC) third quarter profit slipped 28.4 percent year-on-year (YoY) to Rs 19.4 crore, hit by provision of Rs 45.50 crore for forseeable loss. It was also hit by lower revenue but operational performance supported bottomline.

IndusInd Bank Q1 NIM, asset quality seen stable; NII up 22%

Its net interest income (NII) is seen growing 21.75 percent at Rs 975.24 crore against Rs 801 crore year-on-year. NIMs may come in at 3.65 percent while provision may decrease to Rs 97.4 crore versus Rs 107.44 crore on sequential basis.

Central Bank of India Q4 net rises 7% to Rs 174 crore

State-owned Central Bank of India has registered a rise of 7.3 percent in its net profit to Rs 174.29 crore for the quarter ended March 31. The bank had posted a net profit of Rs 162.44 crore in the corresponding period last year.

TV18 Broadcast Q3 net profit jumps 16.8% to Rs 60.4 cr

Revenue from media operations increased to Rs 605.15 crore from Rs 503.6 crore while film production and distribution revenue declined to Rs 11.99 crore from Rs 35.53 crore on year-on-year basis

Banks to provision 15% for 2nd recast of MFI loans: RBI

There have been reports that five heavily indebted MFIs - Bhartiya Samruddhi Finance (Basix), Asmitha Microfin, Spandana Sphoorty Financial, Share Microfin and Trident Microfin, had approached the central bank last month for allowing them to recast their loans for a second time.

IOB Q3 net up 7% to Rs 116cr, provisions jump; shares fall

State-owned lender Indian Overseas Bank's (IOB) net profit rose by 7.4 percent year-on-year to Rs 116 crore in the third quarter of financial year 2012-13, impacted by higher provisions.

Triveni Engg to make additional provision of Rs 79cr

Triveni Engineering will make additional provision of Rs 79 crore this year post the SC judgment of SAP for season 06-07, reports CNBC-TV18.

Ranbaxy US settlement positive, but penalty high: Analysts

Ranbaxy's consent decree with the US Food and Drugs Administration [FDA] to resolve its long pending issue related to the drug regulator blacklisting its plants in Dewas and Paonta Saheb is a positive step analysts say.

Ranbaxy falls as US settlement provision to hurt earnings

Shares of Ranbaxy Laboratories fell over 3% on Wednesday after the drug maker said it has signed a consent decree with the US Food and Drug Administration [FDA] and also has separately set aside USD 500 million to cover any potential penalty from an investigation by the US Justice Department.